GXP-Storage® ("GXP"), the premier provider of regulated material management biostorage solutions, today announced the formation of its Advisory Board. The board, comprised of distinguished industry leaders, will provide strategic guidance to advance GXP’s data-driven biostorage solutions and AI-powered material management. This initiative highlights GXP’s commitment to innovation, compliance, and operational excellence in regulated research, manufacturing, and healthcare material management.
“As we expand our data-driven biostorage solutions, establishing our Advisory Board is a key milestone for GXP,” said Founder and CEO Jeff Johnson. “Our advisors bring deep expertise in regulated research, manufacturing, and healthcare, helping us accelerate the development of advanced material management solutions. Their insights will enable us to introduce new, data-driven services faster, empowering clients to manage their regulated materials more efficiently and cost-effectively.”
Advisory Board Members
GXP has assembled a world-class team of experts with diverse expertise in regulatory compliance, AI-powered solutions, and healthcare technology. Notable members include:
- Paul Heath - Business Development Director (biospecimen and biomarker / biological sample management) at Discovery Life Sciences
- Edmund Jackson - CEO of UnityAI and former Chief Data Scientist at HCA Healthcare, with a focus on AI innovation in human health
- Alan Jones - VP of Regional Business Development at Integrated Project Services (IPS), specializing in Life Sciences
- Dr. Andrew Litt - CEO, Cornice Health Ventures, LLC; Former executive at GE Healthcare, CMO for Dell Healthcare & Life Sciences Division, Vice Dean at NYU Langone Medical Center
- Dr. George Magrath, MD, MBA - CEO and Board Member of Opus Genetics and former CEO of Lexitas Pharma Services, with a focus on clinical human health innovation
- Keith Meadors - Vice President and General Manager, South Atlantic Region, Atlantic Division, Labcorp, a leader in healthcare diagnostics, pharmaceuticals, and medical devices
- Bill Monteith - Biomanufacturing Forum Program Director, NC Life Sciences Organization (Retired Pharma and Biotech Executive)
- Chris Otto - President, CR Otto Consulting; Former Global AVP, Clinical Laboratory Services, Eli Lilly
- Mark Phillips - VP Statewide Operations, NC Biotechnology Center, with a focus on human health and AgTech
- Markus Saba - Professor of the Practice of Marketing, UNC Kenan-Flagler Business School; Former Senior Director of Global Commercialization, Eli Lilly
- Ben Shaw - Partner, Borealis Ventures; Founder & CEO, Blue Rabbit, specializing in veterinary healthcare technology and services
- Dr. Praveen Soti, MD, MBA - Managing Director of Healthcare and Life Sciences at Brillio, Former President of Emids, specializing in AI advisory for healthcare enterprises and former President of Emids
Leading the Future of Tech-Enabled Regulated Material Management
The formation of GXP’s Advisory Board is critical as organizations increasingly seek data-driven biostorage solutions to enhance visibility, streamline compliance, and accelerate research and manufacturing. GXP’s proprietary GXP-Guardian® system is designed to meet stringent regulatory requirements, managing billions of regulated material records while leveraging AI to unlock deeper insights and efficiencies.
Historically, biostorage solutions have been fragmented, often forcing trade-offs between compliance, security, and operational efficiency. GXP is transforming the industry by integrating advanced AI technology with expert-driven strategies, delivering a scalable, secure, and compliant solution that eliminates these conflicts.
Expanding Capabilities to Meet Growing Industry Demand
To support the increasing need for secure, AI-powered biostorage, GXP has made significant infrastructure investments. In May 2024, the company added over 200,000 cubic feet of secure storage at its Nash County, NC facility to support the growing demands of regulated research and manufacturing for restricted access storage and data-driven solutions. Additionally, GXP is further expanding its Middlesex, NC, campus to increase capacity and meet the evolving needs of the industry.
These expansions reinforce GXP’s commitment to providing cost-effective, scalable, and fully compliant biostorage solutions for the life sciences, healthcare, and biopharmaceutical sectors. By integrating AI-powered automation, advanced security protocols, and regulatory oversight into the GXP-Guardian platform, GXP sets a new standard for efficiency, reliability, and compliance in regulated material management.
About GXP-Storage
GXP provides intelligent, data-driven biostorage solutions that empower clients to streamline operations while ensuring regulatory compliance and operational excellence. Leveraging the validated GXP-Guardian regulated material management system, GXP delivers real-time visibility, predictive analytics, and precise control over regulated materials, optimizing inventory consolidation, management, and distribution.
With decades of experience, GXP’s leadership has established a trusted reputation for delivering high-quality, technology-driven biostorage solutions tailored to regulated research, manufacturing, and healthcare needs. Located in the Research Triangle Park (“RTP”) and BioPharma Crescent region of North Carolina, GXP’s state-of-the-art campus offers millions of cubic feet of environmentally controlled, restricted-access storage, ensuring secure, efficient, and scalable storage with seamless logistics integration for rapid retrieval and distribution. To learn more or contact us, go to https://gxp-storage.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250401219217/en/
Contacts
Media Contact
Greg Behr
Brasco Marketing
gregb@brasco.marketing